Slideshow: Exploring Dementia Risk, Hot Flashes, Oral Health in Postmenopausal Women

Menopause is characterized by a decline in ovarian function. Estrogen and progesterone, key players in regulating the menstrual cycle, decrease significantly; as a result, the menstrual cycle ceases altogether. This hormonal balance ushers in a wave of symptoms, such as hot flashes, sleep disturbances, and mood swings. It also raises the risk for more serious health concerns, including bone loss and certain cancers.

Four posters presented at the Endocrine Society’s 2024 annual meeting, held June 1 to 4 in Boston, Massachusetts, explored the interplay of hormones and other factors in women during and after menopause. Findings offer critical insights into preventive measures and early detection for various health risks women might face as they age.

Click here for more of our coverage from ENDO 2024.

READ MORE: Women’s Health Resource Center

Pharmacy practice is always changing. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.

References

1. Nataliyah T, Ahmad S, Batra K, Gupta A, Izuora KE. Assessing the relationship between oral health and bone disease among post-menopausal women. Presented at: ENDO 2024; June 1-4, 2024; Boston, MA.

2. Yu J, Han K, Yun J, Lee S. Risk of dementia according to the reproductive factors in postmenopausal women with diabetes. Presented at: ENDO 2024; June 1-4, 2024; Boston, MA.

3. Armeni E, Augoulea A, Karagkouni I, et al. The severity of vasomotor symptoms is associated with metabolic dysfunction associated liver disease (MASLD) in peri- and postmenopausal women. Presented at: ENDO 2024; June 1-4, 2024; Boston, MA.

4. Allen-Brady KL, Verrilli L, Alvord M. Breast and ovarian cancer are increased in women with primary ovarian insufficiency and early menopause and cancer is increased in family members. Presented at: ENDO 2024; June 1-4, 2024; Boston, MA.